Invex Therapeutics Ltd (ASX:IXC)
0.0930
-0.0020 (-2.11%)
Apr 16, 2026, 11:56 AM AEST
Invex Therapeutics Market Cap
Invex Therapeutics has a market cap or net worth of 6.99 million as of April 17, 2026. Its market cap has increased by 25.68% in one year.
Market Cap
6.99M
Enterprise Value
2.39M
Revenue
229.08K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.09
Market Cap Chart
Since July 5, 2019, Invex Therapeutics's market cap has decreased from 59.13M to 6.99M, a decrease of -88.18%. That is a compound annual growth rate of -27.00%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 16, 2026 | 6.99M | -22.50% |
| Dec 30, 2025 | 9.02M | 81.82% |
| Dec 23, 2024 | 4.96M | -18.52% |
| Dec 27, 2023 | 6.09M | -85.14% |
| Dec 28, 2022 | 40.96M | -22.70% |
| Dec 31, 2021 | 52.98M | -1.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jul 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Patrys | 13.92M |
| Bio-Gene Technology | 10.98M |
| AdAlta | 10.20M |
| Tissue Repair | 9.98M |
| Immuron | 9.15M |
| Vectus Biosystems | 8.02M |
| Biotron | 6.75M |
| Chimeric Therapeutics | 6.63M |